AI in Oncology Takes Off, Tackling HIV and Liver Disease, Pharma’s Recent Gains
The episode recaps highlights from the AACR conference, emphasizing that AI is moving from pre‑clinical research into clinical oncology, but adoption is hampered by low digital pathology uptake (under 10% of U.S. labs), trust issues, and infrastructure costs. It then shifts to two breakthrough studies: a CRISPR‑based genome‑wide screen in primary human CD4+ T cells that identified new antiviral proteins (PI16 and PPID) that can block HIV infection, and a bioengineering approach to grow a small “satellite” liver implant that expands in‑situ to support patients awaiting a full transplant. The guests—Jen editors and AI reporter—provide expert perspectives on the technical challenges and potential patient impact of these innovations.
Dr George Fareed and Dr Paul Oosterhuis on the Breakthroughs with Turbo-Cancer Treatment
In this episode, Dr. George Fareed and Dr. Paul Oosterhuis discuss their "Turbo‑Cancer" protocol, a repurposed‑drug regimen originally developed for COVID‑19 that they claim has treated between 10,000 and 20,000 patients. They outline the core components—hydroxychloroquine, zinc, doxycycline or azithromycin,...
Ep 373 - Does Bone Predict Hypertrophy?
In this episode of Iron Culture, Eric Trexler and Dr. Eric Helms discuss the challenges of returning to training after long-term detraining and injury, emphasizing the importance of habit formation and auto‑regulation. They explore whether bone geometry can predict muscle...
BI 236 Liset De La Prida: Neurons, Ripples, and Manifolds
In this episode, Lisette de la Prida discusses the complex role of hippocampal sharp‑wave ripples (SWRs) and how they relate to neural manifolds—low‑dimensional structures that capture coordinated population activity. She explains that ripples are not a single, uniform phenomenon but...
Green Frequency
Green Frequency explores cutting‑edge environmental research and frontline conservation stories, covering topics such as forest regeneration, long‑term ocean carbon storage, and the legal tactics used to win environmental lawsuits. The episode highlights how scientific insights translate into real‑world policy and...
Scaling Bio 008: Serif Biomedicines' Jake Rubens on Turning Modified DNA Into a New Class of Medicine
In this episode, Jake Rubens of Serif Biomedicines explains how the company is turning DNA into a new class of medicines by using chemically modified DNA and a protein co‑factor to overcome DNA’s historic immunogenicity and delivery challenges. He contrasts...
Dr. Ryan Cole on Defending His Medical License and Improving Health
In this episode, Dr. Ryan Cole discusses his recent battle defending his medical license, his new role leading medical and scientific affairs at the Independent Medical Alliance, and his advocacy for free‑speech rights in medicine following a landmark Supreme Court...
Keto Saved My Life — The Future of Metabolic Medicine | Nick Norwitz PhD MD
In this episode, Dr. Nick Norwitz, a PhD in human metabolism and new Harvard MD, shares how a ketogenic diet rescued him from severe ulcerative colitis, leading to complete remission and allowing him to finish his PhD and medical training....
Cancer Breakthrough Suppressed?
In this episode, Dr. Peter McCullough discusses a human observational study conducted by the Wellness Company on an off‑label combination of ivermectin and benazole for various solid‑tumor cancers. Among roughly 200 participants, 84% reported positive outcomes, with 48% experiencing tumor regression...
Inside SatEnlight's Spiral Staircase of Lasers: Interview with Startup Space Winner Matteo Vismara
In this episode, Jeffrey Hill interviews Matteo Vismara, CEO and co‑founder of Italy‑based SatNlight, the winner of the Sat Show’s 10th annual Startup Space Entrepreneur Pitch Contest. Vismara explains how his team’s optical‑communication terminal uses stacked vortex beams—visualized as a...
Paper on Terahertz-Band ISAC Receives Coveted IEEE Mimno Award
The episode explores the upcoming 6G paradigm shift toward Integrated Sensing and Communications (ISAC), where terahertz‑band radio waves will simultaneously transmit data and act as radar. It explains the physics challenges of terahertz frequencies—severe atmospheric absorption, massive path loss, and...
Can Violence Be an Epidemic? Sam Osterhout & Dr. Gary Slutkin, Epidemiologist and Author
In this episode, Dr. Gary Slutkin argues that violence functions like an infectious disease, spreading through social networks via mechanisms such as mirror‑neuron copying, shared pain pathways, and dopamine‑driven reward systems. He explains the "violence interrupter" model, where trusted community members...
Quantum Chemistry's Classical Limits with Garnet Chan
In this episode, host Sebastian Hassinger talks with Garnet Chan, a leading computational chemist at Caltech, about the true boundary between classical and quantum capabilities in chemistry. Chan explains the significance of the nitrogenase enzyme’s FeMo cofactor, a benchmark often...
861: Engineering Novel Solutions for Data Storage and Energy Management in Electronics - Dr. Eric Pop
In this episode, Dr. Eric Pop, a Stanford professor and former Intel engineer, discusses his interdisciplinary work at the nexus of nanomaterials, electronics, and energy management. He explains how phase‑change materials enable low‑power data storage by toggling between amorphous and...
Major Antineoplastic Mechanisms of Combination Ivermectin-Mebendazole
In this episode of American Sunrise, chief scientific officer Dr. Peter McCullough discusses a new wellness‑company study showing that the antiparasitic drugs ivermectin and mebendazole, when used alongside standard cancer therapies, yielded an 84% positive net clinical benefit in over 200...